In this study, the in vivo effect of the crude extract and n-butanol and aqueous residual fractions of Baccharis articulata (Lam.) Pers. on serum glucose levels, insulin secretion and liver and muscle glycogen content, as well as in vitro action on serum intestinal disaccharidase activity and albumin glycation were investigated. Oral administration of the extract and fractions reduced glycemia in hyperglycemic rats. Additionally, the n-butanol fraction, which has high flavonoids content, stimulated insulin secretion, exhibiting an insulinogenic index similar to that of glipizide. Also, the n-butanol fraction treatment significantly increased glycogen content in both liver and muscle tissue. In vitro incubation with the crude extract and n-butanol and aqueous residual fractions inhibited maltase activity and the formation of advanced glycation end-products (AGEs). Thus, the results demonstrated that B. articulata exhibits a significant antihyperglycemic and insulin-secretagogue role. These effects on the regulation of glucose homeostasis observed for B. articulata indicate potential anti-diabetic properties.

This study analyzed the performance, antioxidant status, hepatopancreatic lipoperoxidation, and proximate composition of Macrobrachium rosenbergii juveniles fed diets supplemented with clove basil (Ocimum gratissimum) essential oil (EO-OG). A total of 360 M. rosenbergii (initial weight 0.028 g ± 0.004) were randomly divided into four experimental groups with six replications each (n = 6). The prawns were fed diets with different EO-OG inclusion levels: 0.0, 1.0, 2.0, and 3.0 g kg⁻¹ EO-OG. After a 42-day feeding trial, dietary EO-OG showed no significant effect on prawn performance or carcass proximate composition, except on final antenna length. Prawns fed 3.0 g kg⁻¹ EO-OG displayed a 1.2- to 1.3-fold longer final antenna length than prawns from all other experimental groups. Likewise, prawns fed 3.0 g kg⁻¹ EO-OG presented a 2.6- to 3.2-fold higher catalase activity than prawns from all other experimental groups. Prawns fed EO-OG, regardless of the inclusion level, showed a 1.6- to 1.7-fold decreased hepatopancreatic lipoperoxidation compared to the control group. Therefore, EO-OG has been demonstrated to be a potential management tool as a non-nutritional dietary immunostimulant and animal welfare promoter for freshwater prawn farming, without affecting animal performance. This study recommends the dietary inclusion level of 3.0 g kg⁻¹ EO-OG for M. rosenbergii juveniles.

The objective was to evaluate the effects of partial replacement of fish meal with protein hydrolysates and a commercial product in the diets of Penaeus vannamei post-larvae on zootechnical performance, proximate chemical composition, digestive enzyme activity, and total hemocyte count. The experiment was conducted in a clear water recirculation system comprising 24 experimental units, each with 30 shrimp with an average weight of 0.2 g. The treatments were control, chicken protein hydrolysate (CPH), enzymatic hydrolysate of chicken feathers, Aquabite^®, CPH + maltodextrin, and CPH + yeast, with four replicates each. The inclusion level of the different protein sources evaluated was 6%. At the end of the experiment, all shrimp were counted, weighed, and measured to determine the zootechnical performance. The body and feed chemical compositions, as well as the enzymatic activities of the hepatopancreas and the total hemocyte count in the hemolymph, were analyzed. The data obtained were subjected to ANOVA and Tukey’s test. There was no statistical difference between the treatments in any of the analyzed parameters. The results showed that all the evaluated protein hydrolysates can be used as partial substitutes for fish meal in P. vannamei diets during the nursery phase, maintaining equivalent and adequate digestive enzyme activities, health, growth, and body composition of the shrimp, in addition to being ecologically sustainable ingredients.